The Top Line
A cell therapy reckoning
May 31, 2024
Fierce Biotech members Annalee Armstrong and Gabrielle Masson discuss the challenges and advancements in cell therapy, including a notable shift towards autoimmune treatments, manufacturing constraints, and the potential impact of CAR-T therapy in various medical fields.
06:31
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Cell therapy industry faces challenges in clinical trials and manufacturing.
- Experts express optimism but also caution about the future of cell therapy, emphasizing the need for innovation and adaptation.
Deep dives
Challenges and Changes in Cell Therapy
The podcast episode delves into the challenges and transformations in the field of cell therapy. It highlights the significant clinical hurdles, manufacturing limitations, and major shifts within the industry. With examples such as the closure of legacy businesses by big pharmas like NOFI and Bristol Myers-Quib, as well as the move towards autoimmune indications, the episode emphasizes the dynamic nature of cell therapy and the need for continuous adaptation and innovation.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
